Evidence map›Paper›PMID 38146141›Full record

ArticleClinical cardiology2024

Interleukin-4 and Interleukin-17 are associated with coronary artery disease.

Chenyang Wang, Sheng Liu, Yunxiao Yang, Raimov Kamronbek, Siyao Ni, Yunjiu Cheng, Can Zhou, Huiyuan Yan, Li Li, Hao Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Clinical cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Chenyang WangCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0001-9288-1340
Sheng LiuCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yunxiao YangCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Raimov KamronbekCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Siyao NiCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yunjiu ChengDepartment of Cardiology, Key Laboratory on Assisted Circulation, Ministry of Health, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.ORCID http://orcid.org/0000-0001-6104-9308
Can ZhouCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Huiyuan YanDepartment of Cardiology, Hangjinqi People's Hospital, Inner Mongolia, China.
Li LiLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hao LiuDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yu WangKey Laboratory of Upper Airway Dysfunction-Related Cardiovascular Diseases, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Disease, Capital Medical University, Beijing, China.
Yanwen QinKey Laboratory of Upper Airway Dysfunction-Related Cardiovascular Diseases, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Disease, Capital Medical University, Beijing, China.
Chengqian YinCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ming ZhangCenter for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-2956-4056
Capital Medical University · CNInner Mongolia People's Hospital · CNSun Yat-sen University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

National Natural Science Foundation of China 82170453
6 · The paper itself

Abstract

introductionThe present study aimed to examine the correlation between serum cytokine levels and the incidence of coronary artery disease (CAD), a leading cause of mortality globally, which is known to have a strong association with inflammatory factors. The study further sought to determine the predictors of CAD to distinguish patients with coronary artery lesions from those suspected of having CAD. METHODS AND

resultsIn this study, 487 patients who underwent coronary angiography as a result of suspected CAD but without acute myocardial infarction (AMI) were recruited. The serum levels of the cytokines interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, tumor necrosis factor-α, interferon (IFN)-α, and IFN-γ were measured using a multiplexed particle-based flow cytometric assay technique. The results of the study revealed that the levels of IL-4, IL-12p70, IL-17, IFN-α, and IFN-γ in the CAD group were significantly lower compared to those in the non-CAD group. Multivariate logistic regression analysis indicated that two serum cytokines (IL-4 and IL-17), one protective factor (high-density lipoprotein cholesterol [HDL-C]), and three risk factors (sex, smoking, and diabetes) were independently predictive of CAD. The receiver operating characteristic curve analysis showed that the combined use of these predictors in a multivariate model demonstrated good predictive performance for CAD, as evidenced by an area under the curve value of 0.826.

conclusionThe results of the study indicated that serum IL-4 and IL-17 levels serve as independent predictors of CAD. The risk prediction model established in the research, which integrates these serum cytokines (IL-4 and IL-17) with relevant clinical risk factors (gender, smoking, and diabetes) and the protective factor HDL-C, holds the potential to differentiate patients with CAD from those suspected of having CAD but without AMI.

Indexed as

Coronary Artery DiseaseDiabetes MellitusMyocardial InfarctionCytokinesHumansInterleukin-17Interleukin-4CytokinesIL4 protein, humanInterleukin-17Interleukin-4coronary artery diseasecytokineshigh-density lipoprotein cholesterolinterleukin-17interleukin-4

Identifiers

PMID38146141
PMCPMC10823557
OpenAlexW4390234515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.